7,000 volunteers needed to crack the genetic code of keloids.

NCT ID NCT01619553

Recruiting now Knowledge-focused Sponsor: UConn Health Source: ClinicalTrials.gov ↗

First seen Jun 24, 2026 · Last updated Jun 27, 2026 · Updated 1 time

Summary

This study aims to find the genes that cause or contribute to keloid scarring. Researchers will analyze DNA from 7,000 people who have keloids, as well as their unaffected family members. The goal is to better understand why some people develop these raised scars, which could lead to future treatments.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

What this could lead to: If successful, this could point toward genetic targets for future treatments or prevention of keloid scarring.
What could go wrong: This is an observational genetic study, not a treatment trial. It may not directly lead to new therapies, and results may take years to translate into clinical use.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for KELOID are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

Fibrosis keloid severe cutaneous adverse reaction

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

KELOID

Contacts and locations

Locations

University of Connecticut Health Center (UCHC)
RECRUITING

Farmington, Connecticut, 06030-3705, United States

More trials for these conditions

Other studies related to the condition(s) this trial covers.